Epi proColon® offers a convenient way of detecting colorectal cancer: in blood. It’s as simple as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells.
Epi proColon® is the first and only FDA-approved blood-based test the detection of colorectal cancer. The test is available in the United States, Europe, China and selected other countries.